Granulomatosis with polyangiitis historical perspective
|
Granulomatosis with polyangiitis Microchapters |
|
Differentiating Granulomatosis with polyangiitis from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Granulomatosis with polyangiitis historical perspective On the Web |
|
American Roentgen Ray Society Images of Granulomatosis with polyangiitis historical perspective |
|
FDA on Granulomatosis with polyangiitis historical perspective |
|
CDC on Granulomatosis with polyangiitis historical perspective |
|
Granulomatosis with polyangiitis historical perspective in the news |
|
Blogs on Granulomatosis with polyangiitis historical perspective |
|
Directions to Hospitals Treating Granulomatosis with polyangiitis |
|
Risk calculators and risk factors for Granulomatosis with polyangiitis historical perspective |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Ali Poyan Mehr, M.D. [2];Associate Editor(s)-in-Chief: Amandeep Singh M.D.[3]Krzysztof Wierzbicki M.D. [4]Cafer Zorkun, M.D., Ph.D. [5]
Overview
Granulomatosis with polyangiitis was first discovered by Peter McBride, a Scottish otolaryngologist, in 1897 when describing a case of rapid destruction of the nose and face. In 1907, Heinz Karl Ernst Klinger added information regarding the anatomical pathology of the disease. However, the full presentation of the disease was later discovered in 2 separate reports in 1936 and 1939 by a German pathologist, Friedrich Wegener. The disease was called pathergic granulomatosis. This led to some confusion with lethal midline granuloma and lymphomatoid granulomatosis. In 1954, it was called as Wegener's granulomatosis, named after a German pathologist, Friedrich Wegener who described the disease in his detailed report published in 1936. As of November 7, 2010, the name Wegener's granulomatosis has been changed to Granulomatosis with polyangiitis by the American College of Rheumatology, American Society of Nephrology, and the European League Against Rheumatism. The association between ANCA and Granulomatosis with polyangiitis was made in 1982.
Historical Perspective
Discovery
- Granulomatosis with polyangitis was first discovered by Peter McBride, a Scottish otolaryngologist, in 1897.[1]
- In 1907, Heinz Karl Ernst Klinger added information regarding the anatomical pathology of the disease.
- The disease was called pathergic granulomatososis.[2] This led to some confusion with lethal midline granuloma and lymphomatoid granulomatosis.[3]
- In 1954, it was called as Wegener's granulomatosis [4], named after a German pathologist, Friedrich Wegener who described the disease in his detailed report published in 1936.[5]
- Due to concerns with Wegener's professional conduct, Alexander Woywodt and Eric Matteson abandoned the name and changed to "ANCA-associated granulomatous vasculitis."[6]
- As of November 7, 2010, the name Wegener's granulomatosis has been changed to Granulomatosis with polyangitis by the American College of Rheumatology, American Society of Nephrology, and the European League Against Rheumatism.[7][8]
- The association between ANCA and Granulomatosis with polyangitis was made in 1982.[9][10][11][12][13][14]
Landmark Events in the Development of Treatment Strategies
- In 1973, cyclophosphamide and prednisone was first used by Fauci and Wolf and the disease showed remission.[15]
Famous Cases
- The following are a few famous cases of disease name:
- Heinrich Hertz, famous German physicist who worked on electromagnetic waves[16]
References
- ↑ Friedmann I (1982). "McBride and the midfacial granuloma syndrome. (The second 'McBride Lecture', Edinburgh, 1980)". The Journal of laryngology and otology. 96 (1): 1–23. PMID 7057076.
- ↑ Fienberg R (1955). "Pathergic granulomatosis". Am. J. Med. 19 (6): 829–31. doi:10.1016/0002-9343(55)90150-9. PMID 13275478.
- ↑ Mendenhall WM, Olivier KR, Lynch JW Jr, Mendenhall NP (2006). "Lethal midline granuloma-nasal natural killer/T-cell lymphoma". Am J Clin Oncol. 29 (2): 202–6. doi:10.1097/01.coc.0000198738.61238.eb. PMID 16601443.
- ↑ GODMAN GC, CHURG J (December 1954). "Wegener's granulomatosis: pathology and review of the literature". AMA Arch Pathol. 58 (6): 533–53. PMID 13217569.
- ↑ Wegener F. Ueber generalisierte septische Gefäßerkrankungen [About generalised septic vascular diseases], Verh Deut Pathol Ges , 1936, vol. 29 (pg. 202-10)
- ↑ Woywodt A, Matteson EL (2006). "Wegener's granulomatosis--probing the untold past of the man behind the eponym". Rheumatology (Oxford). 45 (10): 1303–6. doi:10.1093/rheumatology/kel258. PMID 16887845.
- ↑ Falk RJ, Gross WL, Guillevin L, Hoffman GS, Jayne DR, Jennette JC; et al. (2011). "Granulomatosis with polyangiitis (Wegener's): an alternative name for Wegener's granulomatosis". Arthritis Rheum. 63 (4): 863–4. doi:10.1002/art.30286. PMID 21374588.
- ↑ Woywodt A, Haubitz M, Haller H, Matteson EL (2006). "Wegener's granulomatosis". Lancet. 367 (9519): 1362–6. doi:10.1016/S0140-6736(06)68583-8. PMID 16631915.
- ↑ Davies DJ, Moran JE, Niall JF, Ryan GB (1982). "Segmental necrotising glomerulonephritis with antineutrophil antibody: possible arbovirus aetiology?". Br Med J (Clin Res Ed). 285 (6342): 606. PMC 1499415. PMID 6297657.
- ↑ van der Woude FJ, Rasmussen N, Lobatto S, Wiik A, Permin H, van Es LA, van der Giessen M, van der Hem GK, The TH (February 1985). "Autoantibodies against neutrophils and monocytes: tool for diagnosis and marker of disease activity in Wegener's granulomatosis". Lancet. 1 (8426): 425–9. PMID 2857806.
- ↑ Harman, Lynn E.; Margo, Curtis E. (1998). "Wegener's Granulomatosis". Survey of Ophthalmology. 42 (5): 458–480. doi:10.1016/S0039-6257(97)00133-1. ISSN 0039-6257.
- ↑ Helmchen U, Kneissler U, Prall F (1996). "[ANCA-associated forms of vasculitis]". Verh Dtsch Ges Pathol (in German). 80: 38–45. PMID 9065053.
- ↑ "Wegener's granulomatosis and anti neutrophil cytoplasm antibodies (ANCA). Proceedings of a symposium. Zweibrücken, 1990". APMIS Suppl. 19: 1–68. 1990. PMID 2285525.
- ↑ Pradhan VD, Badakere SS, Ghosh K, Almeida A (July 2005). "ANCA: serology in Wegener's granulomatosis". Indian J Med Sci. 59 (7): 292–300. PMID 16062016.
- ↑ Langford CA (May 2011). "Cyclophosphamide as induction therapy for Wegener's granulomatosis and microscopic polyangiitis". Clin. Exp. Immunol. 164 Suppl 1: 31–4. doi:10.1111/j.1365-2249.2011.04364.x. PMC 3095863. PMID 21447129.
- ↑ Feldmann H (June 2005). "[A historic case of Wegener's granulomatosis: the physicist who discovered the electromagnetic waves: Heinrich Hertz]". Laryngorhinootologie (in German). 84 (6): 426–31. doi:10.1055/s-2004-826062. PMID 15940574.